<DOC>
	<DOCNO>NCT02157571</DOCNO>
	<brief_summary>The purpose study use oral prulifloxacin treat patient Acute Exacerbations Chronic Bronchitis compare effect Levofloxacin .</brief_summary>
	<brief_title>A Multi-center , Randomized , Double-blind , Double-dummy Clinical Study Evaluate Safety Efficacy Prulifloxacin Film-coated Tablet Treatment Acute Exacerbations Chronic Bronchitis With Levofloxacin Hydrochloride Tablet Active Control</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Prulifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>1 . Patient willing participate study give signature informed consent ; 2 . In outpatient ( age 1870 year old ) , male female ; 3 . Patient receives effective antibacterial therapy therapy remarkable efficacy , positive bacterial test result past 72 hour ; 4 . Diagnosed mild moderate acute exacerbation chronic bronchitis patient ( see &lt; Severity Evaluation Criteria Table &gt; ) 5 . Within 48 hour prior study , woman childbearing age negative urine pregnancy test willing use efficient measure contraception avoid pregnancy study . 1 . Patient hypersensitive quinolones allergic constitution ; 2 . Patient severe condition need combination antibacterial agent ; 3 . Concurrent infection organ system ; 4 . Patient severe heart , liver kidney disease , QT prolongation 450 m , serum AST ALT twice high upper limit normal Cr upper limit normal ; 5 . With follow disease : active tuberculosis , bronchiectasis , lung abscess , aspiration pneumonia , lung cancer , noninfectious interstitial lung disease , pulmonary edema , atelectasis , pulmonary embolism , pulmonary addict acidic granulocyte infiltration pulmonary vasculitis syndrome ; 6 . Patient severe hematologic disease central nervous system disease convulsion history , mental status unable coordinate ; 7 . Patient malignant tumor severe background disease ; 8 . Patient severe immunodeficiency ; 9 . A history tendon ; 10 . Known pregnancy lactation ; 11 . Prulifloxacin contain lactose , therefore , patient rare genetic disease galactose intolerance , Lapp lactase deficiency glucose galactose malabsorption enrol ; 12 . Participation clinical trial within 3 month screen currently investigational therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>prulifloxacin</keyword>
	<keyword>AECB</keyword>
	<keyword>Levofloxacin</keyword>
</DOC>